Levofloxacin Injection, Solution
Product Images NDC 0409-3330

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Levofloxacin (NDC 0409-3330). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Hospira, Inc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure 1 (Lev20 0000 01)

Chemical structure of Levofloxacin is depicted, showing its molecular framework with rings, bonds, and functional groups typical for a fluoroquinolone antibiotic molecule.*

FDA Label Image

Figure 2 (Lev20 0000 02)

A graph depicting the pharmacokinetic profile of Levofloxacin with plasma concentration on the y-axis and time in hours on the x-axis, comparing two dosages: 750 mg IV infusion and 750 mg oral tablet. The curve shows the change in drug concentration over time for each dosage.*

FDA Label Image

Figure 3 (Lev20 0000 03)

A line graph depicting pharmacokinetic data for Levofloxacin, comparing 500 mg tablet taken orally versus 500 mg intravenous dose. The graph shows concentration levels over time (hours) on the X-axis and drug concentration on the Y-axis, illustrating how plasma levels change post-administration for both routes.*

FDA Label Image

Principal Display Panel – 250 mg/50 mL Carton Label (Lev20 0000 04)

Packaging label for Levofloxacin 250 mg/50 mL (5 mg/mL) in 5% Dextrose Injection, an intravenous injection solution. The label indicates a 24 count of 50 mL bags with infusion instructions to infuse over 60 minutes. The product is labeled by Hospira, Inc and includes direction to leave the bag in overwrap until use.*

FDA Label Image

Principal Display Panel – 500 mg/100 mL Carton Label (Lev20 0000 05)

Packaging label for Levofloxacin 500 mg/100 mL (5 mg/mL) in 5% Dextrose Injection, an intravenous solution. The label indicates a 24 count of 100 mL bags with instructions to infuse over 60 minutes. The product is labeled by Hospira, Inc. and has NDC 0409-3330-24.*

FDA Label Image

Principal Display Panel – 750 mg/150 mL Carton Label (Lev20 0000 06)

Carton label for Levofloxacin 750 mg/150 mL (5 mg/mL) Injection in 5% Dextrose, an intravenous solution. The label indicates a 24 count package of 150 mL bags with infusion over 90 minutes. The labeler is Hospira, Inc. The packaging includes usage instructions, NDC number 0409-4444-24, and manufacturer information.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.